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ABSTRACT We recently showed that at desensitized muscle nicotinic receptors, epibatidine selects by 300-fold between
the two agonist binding sites. To determine whether receptors in the resting, activatible state show similar site selectivity, we
studied epibatidine-induced activation of mouse fetal and adult receptors expressed in 293 HEK cells. Kinetic analysis of
single-channel currents reveals that ()-epibatidine binds with 15-fold selectivity to sites of adult receptors and 75-fold
selectivity to sites of fetal receptors. For each receptor subtype, site selectivity arises solely from different rates of epibatidine
dissociation from the two sites. To determine the structural basis for epibatidine selectivity, we introduced mutations into
either the  or the  subunit and measured epibatidine binding and epibatidine-induced single-channel currents. Complexes
formed by  and mutant (K34SF172I) subunits bind epibatidine with increased affinity compared to  complexes,
whereas the kinetics of 2(K34SF172I) receptors reveal no change in affinity of the low-affinity site, but increased affinity
of the high-affinity site. Conversely, complexes formed by  and mutant (S36KI178F) subunits bind epibatidine with
decreased affinity compared to  complexes, whereas the kinetics of 2(S36KI178F) and 2(S36KI178F) recep-
tors show markedly reduced sensitivity to epibatidine. The overall data show that epibatidine activates muscle receptors by
binding with high affinity to  and  sites, but with low affinity to the  site.
INTRODUCTION
Muscle acetylcholine receptors (AChRs) are heteropenta-
mers of homologous but functionally distinct subunits. Re-
ceptors from fetal muscle have the composition 2,
whereas those from the adult contain the  subunit in place
of  (Mishina et al., 1986). The receptor contains two
acetylcholine (ACh) binding sites, each generated by pairs
of subunits,  and either  or . Although early studies
emphasized contributions of the  subunits to the binding
sites, substantial evidence has accumulated to show that the
non- subunits also contribute to stabilization of bound
ligands (reviewed in Prince and Sine, 1998a).
Owing to the presence of different non- subunits, the
, , and  interfaces confer distinct agonist and antag-
onist affinities for binding sites of fetal and adult receptors.
Kinetic analysis of single-channel currents shows that ACh
activates Torpedo (Sine et al. 1990) and fetal mouse (Zhang
et al., 1995) receptors with 100- and 30-fold site selectivity,
respectively. On the other hand, adult receptors from human
or mouse show either less or undetectable site selectivity
(Ohno et al., 1996; Akk et al., 1996; Wang et al., 1997),
indicating that site selectivity depends on species and sub-
type of the non- subunits. Site selectivity also depends on
functional state, because desensitized receptors show no site
selectivity for the classical agonists ACh and carbamylcho-
line (Sine and Claudio, 1991; Sine et al., 1995a). However,
the novel alkaloid epibatidine, which has fM-pM affinity for
certain neuronal nicotinic receptors (Gerzanich et al., 1995;
Sullivan et al., 1994), selects between sites of desensitized
muscle receptors, binding 300-fold more tightly to the  or
 sites than to the  site (Prince and Sine, 1998b).
Here we use single-channel recording to delineate mo-
lecular steps underlying the activation of muscle AChRs by
()-epibatidine. Kinetic analysis of single-channel events
reveals that epibatidine selects between binding sites of
resting, activatible receptors by 75-fold in the fetal subtype
and 15-fold in the adult subtype. We further show that the
 interface forms the low-affinity binding site, whereas the
 and  interfaces form high-affinity sites. Thus epiba-
tidine activates muscle AChRs with site selectivity opposite
that of ACh, and maintains the same site selectivity for both
activatible and desensitized states.
MATERIALS AND METHODS
Materials
[125I]-labeled -bungarotoxin was purchased from DuPont NEN (Boston,
MA). ()-Epibatidine and proadifen were purchased from Research Bio-
chemicals Incorporated (Natick, MA). A plasmid encoding green fluores-
cent protein (pGreen Lantern) was purchased from Gibco (Gaithersburg,
MD). Sources of AChR subunits were as previously described (Sine,
1993).
Expression of receptor complexes
We transiently transfected 293 HEK cells at 50% confluence, using
calcium phosphate precipitation (Sine, 1993). For patch-clamp studies,
cells were transfected with mouse , , , either  or , and pGreen Lantern
cDNAs in the ratio 2:1:1:1:0.4. For each 35-mm plate of cells we used 2.7
g of the  subunit cDNA. For expression of intracellular complexes, the
transfection mixture included  plus either ,  or mutant subunits in the
ratio 1:1.3. For all binding studies, 13.5 g of  cDNA was used per 10-cm
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FIGURE 1 Kinetics of activation of fetal and adult AChRs by epibatidine. Left panels show traces of individual clusters from (A) adult and (B) fetal
receptors recorded at the indicated concentrations of epibatidine. The traces are displayed at bandwidths of 9 kHz for the fetal receptor and 10 kHz for
the adult receptor. The smooth curves through the open and closed time histograms are theoretical probability density functions calculated from the
fitted rate constants for Scheme 2, with values given in Table 2.
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FIGURE 1 Continued.
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plate. After incubation in the DNA/calcium phosphate medium for 12–
16 h, the medium was replaced with normal growth medium. For patch-
clamp studies the cells were maintained for a further 12–24 h at 37°C, and
for 36–48 h for binding studies.
Patch-clamp recordings
Single-channel currents were recorded in the cell-attached configuration as
previously described (Wang et al., 1997). Transfected cells were identified
under fluorescence optics by their expression of green fluorescent protein.
All recordings were obtained at a membrane potential of 70 mV and a
temperature of 23–25°C. Both bath and pipette solutions contained (in
mM) 142 KCl, 5.4 NaCl, 1.8 CaCl2, 1.7 MgCl2, and 10 HEPES (pH 7.4).
Epibatidine was included in the electrode solution at specified concentra-
tions. Single-channel currents were recorded with an Axopatch 200A
amplifier at an initial bandwidth of 50 kHz. Currents were digitized using
an ITC-16 analog-to-digital interface at a sampling rate of 6 s and
recorded to the hard disk of a Power Macintosh 7100 with the program
Acquire (Bruxton Corporation, Seattle, WA). Data were acquired during
periods of receptor activation by triggering currents exceeding 40% of the
typical amplitude of the channel being studied, and acquisition was initi-
ated 300 ms before the triggering event and terminated 300 ms after the last
triggering event. Currents were detected at a final bandwidth of 9 kHz
(fetal receptor) or 10 kHz (adult receptor) by the half-amplitude criterion,
using TAC 2.51 (Bruxton Corporation). Open and closed duration histo-
grams were constructed and fit by the sum of exponentials, using TACFIT
(Bruxton Corporation).
At the epibatidine concentrations used in this study, events correspond-
ing to activation of a single channel were identified as clusters of closely
spaced openings preceded and followed by long closings. Cluster bound-
aries were defined as any closings longer than the duration at which the
main component of closings in the histogram intersected the succeeding
closed time component. For example, at 3 M epibatidine, the main
component of closings had a time constant of 20–30 ms, the succeeding
component had a time constant of 100–150 ms, and cluster boundaries
were typically defined as closings of 100 ms or longer. An unavoidable
consequence of defining clusters of channel activity in this manner is that
we cannot account for trailing and leading closed times, i.e., the closed
dwell times that occur after the receptor recovers from desensitization, but
before the channel opens, and those that occur between the last opening in
a cluster and entry of the receptor into the desensitized state. We dealt with
this problem in two ways. First, we deleted the final opening in each
apparent cluster to yield equal numbers of openings and closings. Second,
only clusters containing 10 or more openings were included in the analysis.
Using this method, we expect the cluster open probability (Popen) to be
overestimated by a maximum of 10%. However, the true error is likely to
be much lower, because even at the lowest concentrations of epibatidine,
clusters contained an average of 30–40 openings. At lower concentrations
of epibatidine there is less desensitization and therefore a greater number
of active channels in the patch. Therefore, to minimize errors in assigning
cluster boundaries at low concentrations of epibatidine, we analyzed only
recordings from patches with lower channel activity. Any clusters in which
two receptors opened simultaneously were rejected. For each cluster within
a recording, we calculated the popen and mean open duration (topen) and
plotted their distributions to determine kinetic homogeneity. Both Popen
and topen distributions typically consisted of one major component, of
roughly Gaussian shape, with small contributions from clusters with very
different kinetic properties. All clusters with Popen and topen within two
standard deviations of the mean of the major distribution were selected for
further analysis. Selection typically included80% of the original clusters.
Selected clusters were transferred to an IBM RS6000 computer and ana-
lyzed with the program MIL (Qin et al., 1996). MIL calculates the likeli-
hood of obtaining the observed distributions of open and closed durations
given a particular kinetic scheme (for schemes see Results), and maximizes
the likelihood by optimizing the rate constants in the scheme. For the fetal
receptor we included recordings at 2, 3, 6, 10, 20, 30, 60, and 100 M
()-epibatidine in the analysis, and for the adult-type receptor 3, 6, 10, 20,
30, 60 and 100 M. After fitting, the probability density function computed
from the kinetic scheme and the derived rate constants (Qin et al., 1996)
was superimposed on the experimental dwell time histograms.
FIGURE 2 Open channel block of
fetal and adult AChRs by epibatidine.
topen is the mean open time at the indi-
cated concentrations of epibatidine.
The traces are displayed at bandwidths
of 9 kHz for the fetal receptor and 10
kHz for the adult receptor. The data are
fit by the equation 1/topen  [epibati-
dine]  kb  , where kb is the
association rate for epibatidine at the
channel block site and  is the appar-
ent channel closing rate. The derived
parameters are given in Table 1.
TABLE 1 Kinetic parameters derived from analysis of open
channel block
kb (M1 s1) kb (s1)  (s1)
Fetal 52.5  1.4 5591  168 695 114
Adult 69.2  3.3 4313  402 3183 321
(K34SF172I) 49.3  0.4 5445  369 323 21
(S36KI178F) 50.6  1.6 6804  93 1122 312
(S36KI178F) 54.9  8 6181  716 5360 1560
kb and  were calculated by linear regression to the equation 1/topen 
[epibatidine]  kb  , where kb is the association rate for epibatidine
at the channel block site and  is the apparent channel closing rate. For
wild-type receptors and (K34SF172I), kb is the mean of 1/tblock at
100 M epibatidine, where tblock is the time constant of the closings
corresponding to channel block. For (S36KI178F) and
(S36KI178F), kb was calculated using data obtained at 60 M and
100 M epibatidine. All parameters are expressed  SE, with errors
derived from linear regression. For wild-type and (K34SF172I)
receptors at least three determinations were made at each concentration,
with each replicate treated independently in the regression analysis. For
receptors containing (S36KI178F), data are from single experiments.
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Ligand binding measurements
Epibatidine binding to intracellular complexes was performed as previ-
ously described (Prince and Sine, 1996). The following form of the Hill
equation was fitted to the binding data:
1	 fractional occupancy
 1	 A	n/
A	n Kappn  (1)
where [A] is the agonist concentration, n is the Hill coefficient, and Kapp is
the apparent dissociation constant.
RESULTS
Basic observations
To investigate the kinetics of receptor activation by epiba-
tidine, we recorded single-channel currents from 293 HEK
cells transfected with , , , and either  (fetal receptor) or
 (adult receptor) subunits. At ()-epibatidine concentra-
tions from 2 M to 200 M (fetal receptor) or 3 M to 200
M (adult receptor), single-channel currents appear in
clearly defined clusters (Fig. 1). Each cluster begins with
the transition of a single receptor from the desensitized to
the activatible state, followed by a period of channel activ-
ity, and then terminates by return to the desensitized state.
Previous work established that the kinetics of activation can
be investigated by analyzing single-channel activity within
identified clusters (Sakmann et al., 1980; Sine and Stein-
bach, 1987; Sine et al., 1990). Thus for each epibatidine
concentration we constructed open and closed time histo-
grams of events within clusters.
Considering first the intracluster closed time histograms,
both fetal and adult receptors exhibit two or three discern-
ible peaks, or exponentials, depending on epibatidine con-
centration (Fig. 1). At low concentrations of epibatidine, the
longer of these exponentials dominates (time constant 30
ms at 3 M) and moves to briefer durations as the epiba-
tidine concentration is increased. The second major compo-
nent (time constant 0.2 ms) contributes little to the closed
time histogram at low concentrations, but its fractional area
increases with increasing concentration. The time constant
of this second component remains unchanged across the
range of epibatidine concentrations. The third and briefest
component (time constant 20–50 s) is separated from the
other components only at epibatidine concentrations less
than 20 M; at higher concentrations it is masked by the
growing envelope of 0.2-ms closings.
Turning to the open time histograms, the major compo-
nent of long openings is accompanied by a briefer compo-
nent with fractional area that decreases with increasing
epibatidine concentrations (less than 10 M epibatidine).
The concentration dependence of brief and long openings
suggests that they correspond to receptors with one and
two sites occupied by epibatidine, respectively. In addi-
tion, for both fetal and adult receptors, the mean duration
of long openings decreases with increasing epibatidine
concentrations.
The basic observations indicate an activation process
driven by epibatidine concentration, plus open channel
block by epibatidine. Considering first open channel block,
its hallmarks are a concentration-dependent decrease in
mean open time, a concentration-dependent increase in the
fractional area of one closed time component, and constant
mean duration of the corresponding closed intervals across
all blocker concentrations. Accordingly, mean open time
topen depends on epibatidine concentration thus:
1/topen
 A	  kb 
where [A] is epibatidine concentration, kb is the block
association rate, and  is the apparent channel closing rate
(Neher and Steinbach, 1978).  is expected to be slower
than the true closing rate, , because bandwidth limitations
prevent resolution of very brief channel closings. For both
fetal and adult receptors, 1/topen increases linearly with
increasing epibatidine concentration (Fig. 2). The ordinate
intercept gives the closing rate constant, which is faster for
adult than for fetal receptors (Table 1). The mean blocked
TABLE 2 Kinetic parameters for epibatidine activation of adult, fetal, and (K34SF172I) receptors
k1 k1 K1 (M) k2 k2 K2 (M)
Adult Scheme 1 375 30 3726  400 10 331  9 49400  1500 149
Scheme 2 300  21 3533  374 11.8 356  10 44200  1020 124
Fetal Scheme 1 118 16 238  40 2.02 113  4 17700  640 156
Scheme 2 112  14 231  27 2.06 113  3 17400  564 154
(K34SF172I) Scheme 1 253  36 39  7 0.16 180  3 21572  477 119
Scheme 2 248  33 38  5 0.15 180  4 21538  304 119
1 1 1 2 2 2 kb kb KB (M)
100  13 10400  747 0.01 9500  838 3660  33 2.6 77.6  1 5720  101 74
105  14 10300  746 0.01 9070  814 3670  63 2.47 76.8  2.5 5708  119 74
13  1 8400  740 0.002 4080  200 782  7 5.22 57.4  0.5 6950  58 121
13  1 8370  530 0.002 4070  294 781  10 5.21 57.4  1 6950  156 121
29  1 9715  281 0.003 11532  477 368  4 31.3 52.2  0.4 6596  63 126
29  1 9717  280 0.003 11532  1057 368  4 31.3 52.3  1 6596  89 126
Parameters were derived from maximum likelihood fitting (see Results) of single-channel data obtained at epibatidine concentrations from 3–100 M for
the adult, 2–100 M for the fetal receptor, and 0.3–60 M for (K34SF172I)). Parameters are expressed  SE. Association constants are given in
units of M1 s1, and all others in units of s1. Schemes 1 and 2 are defined in the text.
Prince and Sine Epibatidine Activation of Nicotinic Receptors 1821
time tblock gives the reciprocal of the unblocking rate con-
stant, kb, which was calculated from the time constant of
the major closed time component at 100 M epibatidine,
where channel blocking events dominate (Table 1).
Maximum likelihood fitting
To derive individual rate constants for steps underlying
activation by epibatidine, we analyzed open and closed
durations according to the following standard kinetic
scheme:
Scheme 1
where k1, k2, and kb are association rate constants for
agonist (A); k1, k2, and kb are dissociation rate con-
stants; R is the closed state of the receptor; R* is the open
state; and RB is the blocked state.  and  are channel
opening and closing rate constants, respectively. To test the
possibility that epibatidine binds independently to the two
sites, we also fit the following expanded scheme to the data:
Scheme 2
Predictions of Scheme 2 differ from those of Scheme 1 by
the presence of an additional closed time component. How-
ever, when k1 and k2 are very different, Schemes 1 and 2
are equivalent because transition out of the A2R state almost
always occurs through the pathway with the faster dissoci-
ation rate constant. To estimate the set of activation rate
constants for epibatidine, we fit predictions of Schemes 1
and 2 to the data with the program MIL. MIL computes the
likelihood of the experimental series of open and closed
times given a set of trial rate constants, and changes the rate
constants to maximize the likelihood (Qin et al., 1996).
Our fitting analysis typically includes dwell times ob-
tained across the entire range of agonist concentrations.
However, because of open channel block by epibatidine, we
analyzed the data in two steps. First we fit the schemes to
data obtained at epibatidine concentrations from 2 M
through 20 M. Here we constrained kb and kb to values
obtained from analysis of channel block described above
(Fig. 2 and Table 1), but allowed the remaining parameters
to vary freely. Our rationale is that determining parameters
associated with occupancy of monoliganded receptors (k1,
k1, 1, and 1) depends on temporal separation of mono-
and diliganded openings, whereas parameters associated
with channel opening (2) depend on temporal separation of
very brief (20–50 s mean) and long closings (30 ms
mean at 3 M epibatidine). Furthermore, excessive channel
block interferes with the temporal resolution of these com-
ponents, either by masking the closed times or by decreas-
ing the open times. Thus favorable conditions for fitting are
achieved at epibatidine concentrations from 2 M through
20 M. Results from this preliminary fit yielded well-
defined estimates of 2, k1, k1, 1, and 1, and theoretical
probability density functions that closely matched our ex-
perimental data, similar to the fitted histograms in Fig. 1.
The second round of fitting included data obtained at
2–100 M (fetal receptor) or 3–100 M (adult receptor)
epibatidine. Because kinetic steps associated with occu-
pancy of the first binding site are obscured by channel block
and are less frequent at high epibatidine concentrations, the
second round of fitting constrained k1, k1, 1, 1, and 2
to values obtained in the first round of fitting, but allowed
k2, k2, 2, kb, and kb to vary freely. For both adult and
fetal receptors, fitting either Scheme 1 or 2 to the data yields
well-defined parameters, which are essentially identical for
the two schemes (Table 2). We also tried fitting in one stage
with all parameters free to vary, and found rate constants
within twofold of those estimated by fitting in two stages
(not shown); the differences likely arise from overrepresen-
tation of blocking events in the one-stage fitting. The fitted
probability density functions calculated from Scheme 2
superimpose on the experimental histograms for epibatidine
concentrations up to 60 M. At 100 M epibatidine, a small
excess of long closings is present, perhaps because of the
averaging across multiple recordings inherent in global fit-
ting, or to an additional class of closings not considered in
Schemes 1 and 2. Finally, values of 2, kb, and kb
obtained by maximum likelihood fitting (Table 2) agree
with parameters obtained by analysis of channel block (Fig.
2 and Table 1).
The fitted parameters indicate fast, nearly diffusion-lim-
ited rate constants for epibatidine association, which are
equal for each binding site of each receptor type, but are
approximately threefold faster for adult compared to fetal
receptors (Table 2). For both fetal and adult receptors, rate
constants for epibatidine dissociation differ between the two
sites, and this difference is solely responsible for the differ-
ent affinities of the sites. The net result of the association
and dissociation rate constants is greater selectivity of epi-
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batidine for sites in fetal than in adult receptors. Comparison
of absolute values of the dissociation constants reveals a
common low-affinity site in both receptor types, but differ-
ent high-affinity sites. Observation of a common low-affin-
ity site suggests that it corresponds to the  site present in
both fetal and adult receptors.
The fitted parameters also reveal channel opening rate
constants five- to tenfold slower than for the natural trans-
mitter ACh (Maconochie and Steinbach, 1998; Zhang et al.,
1995; Wang et al., 1997), whereas channel closing rate
constants are only slightly faster (Table 2). The resulting
channel opening equilibrium constants are much less than
observed for ACh. As observed for ACh, however, epiba-
tidine opens fetal receptors more readily than adult recep-
tors. Finally, although epibatidine blocks open channels
with a forward blocking rate similar to that for ACh, its
unblocking rate is much slower, allowing temporal resolu-
tion of channel blocking events.
As a further check of our fitted parameters, we calculated
the theoretical channel Popen as a function of epibatidine
concentration for both fetal and adult receptors. The kinet-
ically derived Popen curves superimpose on the experimental
data (Fig. 3), further supporting the rate constant estimates.
Epibatidine activates fetal and adult receptors with similar
potency, and achieves a maximum Popen less than 0.5. The
bell shape of the Popen curves results from similar dissoci-
ation constants for epibatidine binding to the transmitter and
the channel blocking sites.
Subunit compositions of the high- and
low-affinity binding sites
We previously showed that carbamylcholine selectivity for
intracellular  and  complexes coincided with the se-
lectivity of resting receptors determined by the kinetics of
single-channel currents (Prince and Sine, 1996). Thus we
measured epibatidine binding to intracellular , , and 
complexes to gain insight into the subunits that form the
high- and low-affinity sites in resting receptors. Epibatidine
binds to intracellular complexes with the rank order  
   (Fig. 4 and Table 3), suggesting that resting
receptors bind epibatidine with similar site selectivity. The
low affinity observed for the  site suggests that it corre-
sponds to the common low-affinity site detected in the
kinetic analysis (Table 2).
Epibatidine binding and kinetics of activation for
receptors with mutant  or  subunits
To directly determine the subunits that form the high- and
low-affinity sites in resting, activatible receptors, we mu-
tated residues in either the  or the  subunit and compared
epibatidine binding to intracellular complexes with binding
parameters determined from the kinetics of single-channel
currents.
We previously showed that the pairs of equivalent resi-
dues, K34/S36 and F172/I178, are major determinants
of carbamylcholine and conotoxin M1 selectivity for the 
and  binding sites (Sine et al., 1995b; Prince and Sine,
1996). In particular, when coexpressed with the  subunit to
form intracellular complexes, the double mutant
(K34SF172I) increases affinity for carbamylcholine,
whereas (S36KI178F) decreases affinity. For epibati-
dine, the mutations affect the affinity of intracellular com-
plexes similarly; (K34SF172I) increases affinity,
whereas (S36KI178F) decreases affinity (Fig. 4). Thus
equipped with mutant  and  subunits that affect epibati-
dine affinity, we sought to determine the subunits that form
the high- and low-affinity sites in fully assembled receptors.
We recorded single-channel currents activated by epiba-
tidine for pentameric cell surface receptors containing either
(K34SF172I) or (S36KI178F) plus complementary
FIGURE 3 Epibatidine dose-response relationships for fetal and adult
AChRs. The overall Popen for each recording was calculated at the indi-
cated concentrations as described in Materials and Methods. Each point
represents the mean  SEM of the overall Popen values from at least three
recordings. The solid lines are the theoretical Popen curves calculated from
the fitted kinetic parameters for Scheme 2 and given in Table 2.
FIGURE 4 Steady-state binding of epibatidine to , ,
(K34SF172I), and (S36KI178F) intracellular complexes. Binding
of epibatidine was measured as described in Materials and Methods. Each
point is the mean of three determinations; the error bars represent the SEM.
Curve fitting parameters are given in Table 3.
TABLE 3 Binding of epibatidine to intracellular complexes
Kd (nM) n
 36.5  6.4 0.68  0.07
 494  45 0.84  0.06
(K34SF172I) 2.1  0.2 0.64  0.0
(S36KI178F) 10820  820 0.97  0.07
 4.8  0.7 0.76  0.08
The parameters and error estimates are derived from fits of Eq. 1 to
cumulated data from at least three independent experiments, with each
replicate treated independently. Each fitted parameter is expressed  SE.
Kd is the apparent dissociation constant, and n is the Hill coefficient.
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wild-type subunits. Coexpression of , , and  with
(K34SF172I) increases sensitivity to epibatidine com-
pared to wild-type receptors, whereas coexpression of , ,
and  with (S36KI178F) greatly diminishes sensitivity
(Fig. 5). For receptors containing (K34SF172I), single-
channel kinetic analysis reveals well-defined rate constants
and probability density functions that superimpose upon the
experimental closed and open time histograms (Fig. 6). The
fitted parameters reveal that (K34SF172I) has little ef-
fect on the low-affinity site, but it increases the affinity of
the high-affinity site to 150 nM (Table 2). This high affinity
for resting receptors owes to a twofold increase of the
association rate, and a sixfold slowing of the dissociation
rate. Furthermore, epibatidine opens (K34SF172I)
receptors more efficiently than wild-type receptors, because
of increased channel opening and decreased channel closing
rates. We previously noted similar effects of these mutations
on receptors activated by acetylcholine (Prince and Sine,
1997). Because the  subunit harbors the mutations, we
conclude that the resting state  site binds epibatidine with
high affinity, whereas the resting state  site binds with
low affinity.
We carried out the converse experiment by coexpressing
(S36KI178F) with complementary subunits from either
fetal or adult receptors. Receptors containing (S36KI178F)
show decreased sensitivity to epibatidine, as expected from
a decreased affinity of the  site (Fig. 5). However, the
marked decrease in affinity prevented clear definition of
clusters, and channel block further obscured events at high
epibatidine concentrations. Thus kinetic analysis was not
feasible for receptors containing (S36KI178F). Never-
theless, the decreased sensitivity produced by (S36KI178F)
further supports assignment of the  site to the resting state
low-affinity site, and  or  sites to resting state high-
affinity sites.
DISCUSSION
This study uses single-channel kinetic analysis to resolve
individual reaction steps underlying epibatidine-induced ac-
tivation of fetal and adult muscle nicotinic receptors. Two
standard and related kinetic schemes quantitatively describe
the kinetics of activation over a 100-fold range of epibati-
dine concentrations. Our results indicate that epibatidine
activates muscle receptors with unique site selectivity, bind-
ing with high affinity to  and  binding sites but with
low affinity to  sites.
Previous studies of AChR activation demonstrated dis-
tinct binding affinities for the natural transmitter ACh at the
two binding sites of the receptor, and that the distinct
affinities originate from different dissociation rate constants
at the two binding sites (Sine et al., 1990; Zhang et al.,
1995; Ohno et al., 1996). Similarly, epibatidine binds with
distinct affinities to activatible fetal and adult receptors,
primarily because of differences in dissociation rate con-
stants at the two sites. The presence of a common  subunit
in the , , and  binding sites suggests that differences
in dissociation rates are due to different contributions of the
, , and  subunits. Mutagenesis and affinity labeling
studies indicate that four loops in each of these non-
subunits contribute to the binding sites (reviewed in Prince
and Sine, 1998a), suggesting that differences in dissociation
rates are due to amino acid differences in one or more of
these loops. Thus structural differences in the non- sub-
units may affect release of epibatidine from its final docking
site or the height of an energy barrier in the pathway out of
the site.
Association rate constants for full agonists approach but
do not equal the theoretical diffusion limit of 1000 M1
s1 (Fersht, 1985). Like full agonists, epibatidine readily
enters the binding site, associating with rate constants be-
FIGURE 5 Epibatidine activation of acetylcho-
line receptors containing either (K34SF172I) or
(S36KI178F) plus complementary subunits. (A)
Fetal type receptors. (B) Adult type receptors. Left
panels show traces of individual clusters recorded
at maximally effective concentrations of epibati-
dine. The traces are displayed at a bandwidth of 9
kHz (fetal type) or 10 kHz (adult type). The right
panels show concentration-response relationships.
The overall Popen for each recording was calculated
at the indicated concentrations as described in Ma-
terials and Methods. For wild-type and
2(K34SF172I) receptors, each point repre-
sents the mean  SEM of the overall Popen values
from at least three recordings. For
(S36KI178F) and (S36KI178F),
each point is a single determination. For wild-type
and 2(K34SF172I) receptors, the smooth
curves represent Popen calculated from the fitted
kinetic parameters for Scheme 2 and given in Table 2.
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tween 100 M and 300 M1 s1. These values are similar
to those previously determined for ACh (Sine et al., 1990;
Zhang et al., 1995; Wang et al., 1997), but are much faster
than for the elementary agonist tetramethylammonium
(Zhang et al., 1995). Association rate constants are very
similar for both binding sites of a given receptor type,
suggesting structurally similar diffusion pathways into the
sites, despite their differing subunit compositions. Further-
more, global structure appears to affect association, as epi-
batidine associates with the  site in the fetal receptor at
100 M1 s1, whereas it associates with the same site in
the adult receptor at more than 300 M1 s1. Thus epi-
batidine readily diffuses into the binding sites, perhaps
encountering modest structural barriers common to both
sites.
Our results show that in activating the AChR, epibatidine
selects between binding sites of the adult receptor by 15-
fold and of the fetal receptor by 75-fold. However, kinetic
analysis alone does not identify which subunits form the
high- and low-affinity binding sites. For ACh and carbam-
ylcholine, assignment of the high- and low-affinity sites
relies on the observation that intracellular  complexes
bind agonist with 30-fold higher affinity than  com-
plexes (Blount and Merlie, 1989; Prince and Sine, 1996).
Because this affinity difference is similar to that determined
by single-channel kinetic analysis (Zhang et al., 1995), the
 site is thought to form the high-affinity activatible site in
fetal AChRs.
To identify which site binds epibatidine with high affin-
ity, we compared relative affinities of intracellular , ,
and  complexes with our kinetically determined binding
affinities. Epibatidine binds to intracellular complexes with
the rank order of affinity   , suggesting that the
 site common to fetal and adult receptors forms the
low-affinity epibatidine site (see also Prince and Sine,
1998b). Our kinetic data support a common low-affinity
site, as we observe similar kinetically derived dissociation
constants for the low-affinity site in fetal and adult AChRs.
To directly identify the subunits that form the high- and
low-affinity sites, we examined single-channel kinetics of
receptors containing mutant  or  subunits. Receptors
containing (K34SF172I) display increased sensitivity to
epibatidine, whereas those containing (S36KI178F) dis-
play decreased sensitivity. Kinetic analysis reveals that
(K34SF172I) increases the affinity of the high-affinity
binding site, without affecting the low-affinity site; the
increased affinity is due primarily to slowing of the rate of
epibatidine dissociation. Thus our results from mutagenesis
provide additional and strong support that the  subunit
pair forms the high-affinity binding site for epibatidine,
whereas the  pair forms the low-affinity site.
We chose the mutations (K34SF172I) and
(S36KI178F) because they strongly affect epibatidine
affinity, and therefore allow us to deliberately alter the
function of either the  or the  site. These mutations
were originally identified in ligand binding studies of the
structural basis of carbamylcholine selectivity for the 
over the  site (Prince and Sine, 1996); the presence of
both mutations in a single receptor nearly reverses the site
selectivity for carbamylcholine. Curiously, however, for
epibatidine the two mutations not only maintain the same
site selectivity, but also markedly increase selectivity to
FIGURE 6 Single-channel re-
sponses of 2(K34SF172I) re-
ceptors to epibatidine. Data were re-
corded at the indicated concentrations
of epibatidine, using a final band-
width of 9 kHz. The smooth curves
through the open and closed dwell-
time histograms are theoretical prob-
ability density functions calculated
from the rate constants derived from
Scheme 2. The fitted rate constants
are given in Table 2.
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approach 10000-fold. Carbamylcholine and epibatidine also
differ in their state dependence of selectivity; carbamylcho-
line selects between sites in the resting but not the desen-
sitized state, whereas epibatidine selects between sites in
both the resting and desensitized states.
Differences between carbamylcholine and epibatidine se-
lectivity suggest the following picture of how the non-
subunits contribute to the binding sites. Residues in multiple
loops of the non- subunits confer agonist selectivity. Some
residues stabilize and others destabilize, but overall agonist
selectivity is the sum of both types of interactions. Further-
more, selectivity depends on the state of the receptor; for a
given agonist the resting state can be selective whereas the
desensitized state is not, or both resting and desensitized
states can be selective. Single-channel kinetic studies of the
fetal receptor show that carbamylcholine selects between
the two binding sites in the resting state (Zhang et al., 1995),
whereas binding studies demonstrate that carbamylcholine
does not distinguish between binding sites in the desensi-
tized state (Prince and Sine, 1998b). The 30-fold selectivity
of carbamylcholine for the resting state owes largely to
residue differences at equivalent positions K34/S36 and
F172/I178. When the receptor desensitizes, residues
K34/S36 and F172/I178 no longer contribute to either
affinity or selectivity, suggesting that they move out of
range of carbamylcholine contact (Prince and Sine, 1996).
For epibatidine binding to the fetal receptor, both the
resting and desensitized states are selective. Our single-
channel data show that epibatidine selects between the
binding sites in the resting state by 75-fold, and our binding
studies show selectivity for sites in the desensitized state of
300-fold (Prince and Sine, 1998b). As we observe for car-
bamylcholine, the determinants K34/S36 and F172/
I178 contribute to selectivity of the resting state, but not to
selectivity of the desensitized state (Prince and Sine, un-
published). Thus the 300-fold selectivity of epibatidine for
desensitized binding sites is due to determinants not yet
identified. In the resting state, these unidentified determi-
nants likely contribute significantly to epibatidine selectiv-
ity, perhaps as much as 300-fold, but the opposing contri-
butions of K34/S36 and F172/I178 yield a net
selectivity of 75-fold.
Our overall results demonstrate opposite site selectivity
of ACh and epibatidine, indicating that the AChR channel
can be opened regardless of the order in which the binding
sites are occupied by agonist. Thus a scheme incorporating
random association of agonist with the two binding sites
(Scheme 2) provides a general description of AChR
activation.
Open channel block also contributes to the Popen of epi-
batidine-activated receptors. Epibatidine is one of the most
potent agonist channel blockers characterized thus far, with
block dissociation constants (KB) of 100 M. For ACh,
KB is 6 mM (Sine and Steinbach, 1984; Wang et al.,
1997). The open channel blocker, QX-222, which is not an
agonist, interacts with adjacent turns of the M2 transmem-
brane domain (Charnet et al., 1990). QX-222 is thought to
hydrogen bond via its quaternary ammonium group to an
annulus of polar groups at position 6 and via its aromatic
group to an annulus of hydrophobic and aliphatic hydroxyl
residues at position 10 (position 1 is the N-terminus of
M2; Miller, 1989). Like QX-222, epibatidine contains a
charged nitrogen and an aromatic moiety. Molecular mod-
eling studies show that the internitrogen separation in epi-
batidine ranges from 4.7 Å to 5.7 Å (Bencherif et al., 1998),
close to the separation between adjacent turns of an -helix.
Thus epibatidine may interact with the receptor channel in a
manner similar to that of QX-222.
In summary, we describe molecular steps underlying
activation fetal and adult muscle receptors by ()-epibati-
dine. Epibatidine is a weak agonist at both receptor types
because of reduced channel opening coupled with high-
affinity open channel block. However, epibatidine shows
unique site selectivity at the AChR, binding with low affin-
ity to the  interface in both receptor types. The unique
properties of epibatidine make it a potentially useful probe
in future structure-function studies.
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